Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
์ข
๋ชฉ ์ฝ๋ ALBT
ํ์ฌ ์ด๋ฆAvalon Globocare Corp
์์ฅ์ผFeb 22, 2016
CEOJin (David)
์ง์ ์5
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃFeb 22
์ฃผ์4400 Route 9
๋์FREEHOLD
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ07728
์ ํ17327804400
์น์ฌ์ดํธhttps://www.avalon-globocare.com/
์ข
๋ชฉ ์ฝ๋ ALBT
์์ฅ์ผFeb 22, 2016
CEOJin (David)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์